Direkt zum Inhalt
Merck

1494909

USP

Pantoprazol-verwandte Verbindung A

United States Pharmacopeia (USP) Reference Standard

Synonym(e):

Pantoprazol-sulfon, 5-(Difluormethoxy)-2-{[(3,4-dimethoxy-2-pyridinyl)-methyl]-sulfone}-1H-benzimidazol

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise


About This Item

Empirische Formel (Hill-System):
C16H15F2N3O5S
CAS-Nummer:
Molekulargewicht:
399.37
Beilstein:
9430498
UNSPSC-Code:
41116107
NACRES:
NA.24

Qualität

pharmaceutical primary standard

API-Familie

pantoprazole

Hersteller/Markenname

USP

Anwendung(en)

pharmaceutical (small molecule)

Format

neat

InChI

1S/C16H15F2N3O5S/c1-24-13-5-6-19-12(14(13)25-2)8-27(22,23)16-20-10-4-3-9(26-15(17)18)7-11(10)21-16/h3-7,15H,8H2,1-2H3,(H,20,21)

InChIKey

FCJYMBZQIJDMMM-UHFFFAOYSA-N

Suchen Sie nach ähnlichen Produkten? Aufrufen Leitfaden zum Produktvergleich

Anwendung


  • Transcriptional profiling for drug repurposing in glioblastoma: This study utilized transcriptional profiling to identify therapeutic targets and repurpose drugs, including pantoprazole-related compounds, for treatment in glioblastoma. This approach underscores the utility of pantoprazole impurities in exploring new therapeutic avenues in pharmaceutical reference material research (Roddy et al., 2023).

  • Gastroprotective agent utilization: A drug utilization study in medicine and surgery wards highlighted the significant role of pantoprazole and its related compounds in managing gastrointestinal protection. This research emphasizes the importance of pantoprazole as a proton pump inhibitor and its impurities in ensuring the efficacy and safety of gastroprotective therapies (Koyani et al., 2023).

  • Synthesis and analysis of pantoprazole sodium sesquihydrate-related compound E: This study explored the synthesis and mechanism of formation of a specific pantoprazole-related compound, offering insights into the chemical stability and quality control of pantoprazole as a pharmaceutical ingredient. Such research is crucial for enhancing analytical methods in pharmaceutical research and ensuring drug safety and efficacy (Yari et al., 2019).

Hinweis zur Analyse

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Sonstige Hinweise

Sales restrictions may apply.

Lagerklassenschlüssel

11 - Combustible Solids

WGK

WGK 3

Flammpunkt (°F)

Not applicable

Flammpunkt (°C)

Not applicable


Analysenzertifikate (COA)

Suchen Sie nach Analysenzertifikate (COA), indem Sie die Lot-/Chargennummer des Produkts eingeben. Lot- und Chargennummern sind auf dem Produktetikett hinter den Wörtern ‘Lot’ oder ‘Batch’ (Lot oder Charge) zu finden.

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

E Doyle et al.
Journal of chromatography, 527(1), 67-77 (1990-04-27)
This paper describes two fully automated assays. One for zaprinast, a cGMP specific phosphodiesterase inhibitor, which uses the Gilson-Advanced Automated Sample Processor combination, and the other for an H+/K+ ATPase inhibitor and its sulphone metabolite, which uses direct injection. Both
Dafang Zhong et al.
The Journal of pharmacy and pharmacology, 57(3), 341-349 (2005-04-06)
We have investigated the metabolism of pantoprazole and have provided an explanation for the formation mechanism of its metabolites. Metabolites found in the urine of rats after oral administration of pantoprazole sodium (25 mg kg(-1)) were analysed by liquid chromatography/ion

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.